SEARCH

SEARCH BY CITATION

References

  • 1
    Richmond R., Indig D., Butler T., Wilhelm K., Archer V., Wodak A. A randomised controlled trial of a smoking cessation intervention conducted among prisoners. Addiction 2013; 108: 966974.
  • 2
    Hall S. M., Lightwood J. M., Humfleet G. L., Bostrom A., Reus V. I., Munoz R. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res 2005; 32: 381392.
  • 3
    Jorenby D. E., Hays J. T., Rigotti N. A., Azoulay S., Watsky E. J., Williams K. E. et al. Efficacy of varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006; 296: 5663.
  • 4
    Seaman A. States with tobacco-free prisons. McLean, VA: USA Today; 2010.
  • 5
    Eldridge G. D., Cropsey K. L. Smoking bans and restrictions in U.S. prisons and jails: consequences for incarcerated women. Am J Prev Med 2009; 37: S179180.
  • 6
    Prochaska J. J., Hall S. E., Hall S. M. Stage-tailored tobacco cessation treatment in inpatient psychiatry. Psychiatr Serv 2009; 60: 848.